JMC | Insilico Medicine publica estratégia inovadora de design baseada em IA para inibidores altamente seletivos de FGFR2/3 (VIDEO)

InSilico Medicine

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.